Phase I and pharmacologic study of 72-hour infused 5-fluorouracil and hyperfractionated cyclical radiation
- 1 April 1985
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 11 (4), 791-800
- https://doi.org/10.1016/0360-3016(85)90313-x
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and X raysInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Clearance of Continuously Infused 5-Fluorouracil in Adults Having Lung or Gastrointestinal Carcinoma with or without Hepatic MetastasesDrug Intelligence & Clinical Pharmacy, 1982
- Intra-arterial chemotherapy using an implantable infusion pump and liver irradiation for the treatment of hepatic metastasesCancer, 1982
- A comparison of combination chemotherapy and combined modality therapy for locally advanced gastric carcinomaCancer, 1982
- Phase I study of protracted venous infusion of 5-fluorouracilCancer, 1981
- Improved Liquid Chromatographic Assay for Serum Fluorouracil Concentrations in the Presence of FtorafurJournal of Pharmaceutical Sciences, 1981
- Infusional 5-fluorouracil and x-ray therapy for non-resectable esophageal cancerCancer, 1980
- Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized studyAmerican Journal of Roentgenology, 1976
- Effects of some Metabolic Inhibitors on X-ray Dose-response Curves for the Survival of Mammalian Cellsin vitro, and on Early Recovery between Fractionated X-ray DosesThe British Journal of Radiology, 1966
- The physiologic disposition of 5‐fluorouracil and 5‐fluoro‐2′‐deoxyuridine in manClinical Pharmacology & Therapeutics, 1964